Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Personalis, Inc. PSNL
$2.08
-$0.01 (-0.72%)
На 18:01, 12 мая 2023
+525.00%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
98012061.00000000
-
week52high
5.58
-
week52low
1.73
-
Revenue
65047000
-
P/E TTM
-920
-
Beta
1.42019000
-
EPS
-2.63000000
-
Last Dividend
0.00000000
-
Next Earnings Date
01 авг 2023 г. в 20:00
Описание компании
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 04 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 06 мая 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 05 мая 2022 г. |
| Citigroup | Buy | Buy | 05 мая 2022 г. |
| Oppenheimer | Outperform | Outperform | 25 февр 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 04 ноя 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 03 ноя 2022 г. |
| Citigroup | Buy | Buy | 03 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Chen Richard | D | 132631 | 562 | 31 янв 2023 г. |
| Tachibana Aaron | D | 206228 | 767 | 31 янв 2023 г. |
| Tachibana Aaron | D | 206995 | 3843 | 20 дек 2022 г. |
| Chen Richard | D | 133193 | 1750 | 20 дек 2022 г. |
| Moore Stephen Michael | D | 88510 | 1930 | 15 дек 2022 г. |
| Tachibana Aaron | D | 210838 | 7177 | 15 дек 2022 г. |
| Chen Richard | D | 134943 | 7177 | 15 дек 2022 г. |
| West John Stephen | D | 239999 | 10000 | 14 дек 2022 г. |
| West John Stephen | A | 622444 | 10000 | 14 дек 2022 г. |
| Chen Richard | D | 142120 | 440 | 02 дек 2022 г. |
Новостная лента
Personalis to Announce First Quarter 2023 Financial Results
Business Wire
19 апр 2023 г. в 16:01
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its first quarter 2023 financial results on Wednesday, May 3, 2023. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights.
Personalis: Revisiting The Investment Thesis
Seeking Alpha
17 апр 2023 г. в 13:11
Today, we put diagnostic firm Personalis, Inc. back in the spotlight as the shares go for less than the company's net cash on the balance sheet. The company has brought in a new CEO and announced significant cost saving measures.
Personalis (PSNL) Upgraded to Buy: Here's What You Should Know
Zacks Investment Research
28 февр 2023 г. в 13:33
Personalis (PSNL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Personalis, Inc. (PSNL) Q4 2022 Earnings Call Transcript
Seeking Alpha
23 февр 2023 г. в 23:36
Personalis, Inc. (NASDAQ:PSNL ) Q4 2022 Results Conference Call February 23, 2023 5:00 PM ET Company Participants Caroline Corner - Investor Relations Aaron Tachibana - Interim Chief Financial Officer and Chief Financial Officer Chris Hall - President Rich Chen - Chief Medical Officer, and SVP of R&D Conference Call Participants Joseph Flanagan - Cowen Vivian Bais - BTIG Arthur He - H.C. Wainwright Operator Good day, ladies and gentlemen, and welcome to the Personalis Fourth Quarter 2022 Earnings Conference Call.
A Short Guide to Making Money With Penny Stocks in 2023
PennyStocks
04 февр 2023 г. в 11:00
Use these tips for making money with penny stocks The post A Short Guide to Making Money With Penny Stocks in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.